Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Toronto

$15,000.00

A platform for massively parallel metabolite analysis in single cells

EF 2020-21

Résumé
The cell is the fundamental unit of biology. However, in the past while we could see single cells within a complicated tissue using a microscope, it was very hard to know what was inside each individual cell - which genes were turned on or off in each cell? How was each cell taking up and processing the rich soup of biological molecules from our diet? How many different types of cell are present in a lump of tissue or in a single organ? This has changed dramatically in the last 5 years as single-cell technologies have revolutionized biology. Instead of having to look at which genes are on or off in an entire mass of tissue (e.g. 'brain' or 'liver') or in a whole tumour, we can now look at which genes are on or off in each individual cell in that tissue or tumour. This has transformed how we look at cancer biology or developmental biology. However, current single cell technologies can only examine RNA and DNA sequences - they cannot measure the many thousands of small molecules and metabolites that are present in each cell. This is a major hole in our understanding. The Fraser group has invented a new method that will allow us to measure hundreds of metabolites in parallel in single cells in a way that is completely compatible with current single cell technologies that measure gene expression. With our invention, we will be able to read both gene expression AND metabolite levels in single cells - this will provide a dramatically new way to see metabolism and drug uptake and processing in each cell of a complex tissue. The proposal here is to fund a deep market analysis. We plan to protect our invention by filing a patent in the next 1-2 months but from that point we will need to engage with knowledge leaders and potential industry partners to see the best route to take our invention to market. This market analysis will be an essential guide to drive this.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
560481-2021
Name nom
Fraser, Andrew
Department département
Donnelly Centre for Cellular & Biomolecular Research
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2021
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
A platform for massively parallel metabolite analysis in single cells
Keyword
NSERC
Application summary
The cell is the fundamental unit of biology. However, in the past while we could see single cells within a complicated tissue using a microscope, it was very hard to know what was inside each individual cell - which genes were turned on or off in each cell? How was each cell taking up and processing the rich soup of biological molecules from our diet? How many different types of cell are present in a lump of tissue or in a single organ? This has changed dramatically in the last 5 years as single-cell technologies have revolutionized biology. Instead of having to look at which genes are on or off in an entire mass of tissue (e.g. 'brain' or 'liver') or in a whole tumour, we can now look at which genes are on or off in each individual cell in that tissue or tumour. This has transformed how we look at cancer biology or developmental biology. However, current single cell technologies can only examine RNA and DNA sequences - they cannot measure the many thousands of small molecules and metabolites that are present in each cell. This is a major hole in our understanding. The Fraser group has invented a new method that will allow us to measure hundreds of metabolites in parallel in single cells in a way that is completely compatible with current single cell technologies that measure gene expression. With our invention, we will be able to read both gene expression AND metabolite levels in single cells - this will provide a dramatically new way to see metabolism and drug uptake and processing in each cell of a complex tissue. The proposal here is to fund a deep market analysis. We plan to protect our invention by filing a patent in the next 1-2 months but from that point we will need to engage with knowledge leaders and potential industry partners to see the best route to take our invention to market. This market analysis will be an essential guide to drive this.